Fig. 51From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (Abstract P115). Progression-free survival estimates by sex in advanced melanoma patients receiving anti-PD-1 monotherapyBack to article page
